Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China
Authors
Zhongqiu Wang (ORCID: https://orcid.org/0000-0001-6681-7345)
Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China
Zhongqiu Wang, Ximei Zhang, Qingxin Wang, Qi Wang et al.
Citations
6 citations
Journal
BMC Medicine
Topics
Head and Neck Cancer Studies
Field-Weighted Citation Impact (FWCI)
11.09
article
Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China
Zhongqiu Wang, Ximei Zhang, Qingxin Wang, Qi Wang, Wei Wang, Jian Sun, Yao Sun, Yanlan Chai, Peiguo Wang
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 23(1)
Institutions
Tianjin Medical University Cancer Institute and Hospital (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China — Zhongqiu Wang, Ximei Zhang, et al. · BMC Medicine (2025) | TGRS Research Map | TGRS